Interestingly, tumor cells constitutively secrete HSP90 and recent studies showed that the plasma level of HSP90α correlates with the pathologic stage of cancer in patients, suggesting the potential of circulating HSP90 as predictive biomarker [29, 48]. This evidence concerns the gene HSP90AA1 and cancer.